Evidence map›Paper›PMID 33644124›Full record

ArticleFrontiers in cardiovascular medicine2020

Piperlongumine Attenuates High Calcium/Phosphate-Induced Arterial Calcification by Preserving P53/PTEN Signaling.

Wenxiang Shi, Jieyu Lu, Junhan Li, Ming Qiu, Yan Lu, Jia Gu, Xiangqing Kong, Wei Sun

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Inflammation and aging: signaling pathways and intervention therapies.Signal transduction and targeted therapy · 2023
    Review
  12. Article
  13. Article
  14. Matrix Vesicles as a Therapeutic Target for Vascular Calcification.Frontiers in cell and developmental biology · 2022
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wenxiang ShiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jieyu LuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Junhan LiDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ming QiuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yan LuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jia GuDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiangqing KongDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wei SunDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular calcification frequently occurs in the process of chronic kidney disease, atherosclerosis and aging, resulting in an increased prevalence of cardiovascular events. Piperlongumine (PLG) is a natural product isolated from

Indexed as

P53piperlonguminePTENSTAT3vascular calcificationVSMCs

Identifiers

PMID33644124
PMCPMC7903972
OpenAlexW3126609717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.